Abstract:Background Sarcopenia is a progressive and generalized skeletal muscle disorder that is associated with an increased likelihood of adverse outcomes, including falls, fractures, physical disability, and mortality. However, there have been few systematic studies of the prevalence and prognostic values of sarcopenia in older patients with coronary heart disease（CHD）. This study aimed to investigate the prevalence of sarcopenia in hospitalized older patients with CHD, and to prospectively evaluate the effect of sarcopenia on the short-term prognosis of these patients. Methods Patients aged ≥ 65 years, with the diagnosis of CHD from Peking Union Medical College Hospital between December 2017 and November 2018, were included. Sarcopenia was diagnosed according to consensus of the Asian Working Group for Sarcopenia in 2014. Follow-up items included unscheduled return visits, occurrence of major adverse cardiac and cerebral events（MACCE）, and all-cause mortality. The MACCE-free survival curve of sarcopenic and non-sarcopenic older patients with CHD was estimated by the Kaplan-Meier method. Cox regression analysis was used to analyze the association between sarcopenia and an unscheduled return visits, MACCE, and all-cause mortality. Results A total of 345 older patients with CHD were enrolled in the study, with a median age of 74 years. Among the patients, 78（22.6%） were diagnosed with sarcopenia. During the follow-up time, there were significantly more unscheduled return visits in sarcopenic patients than in non-sarcopenic patients（34.2% vs. 21.8%, χ~2 = 4.418, P = 0.036）, while there was no significant difference in the occurrence of MACCE（χ~2 = 2.869, P = 0.09） or all-cause mortality（χ~2 = 1.673, P = 0.196） between these patient groups. The Kaplan-Meier curve showed that the MACCE-free survival time of sarcopenic patients was significantly shorter than that in non-sarcopenic patients（χ~2 = 4.102, P = 0.043）. After adjusting for sex, age, and the Charlson comorbidity index, sarcopenia was not an independent risk factor of unscheduled return visits（HR = 1.002, 95% CI: 0.556–1.807）. However, the complication of anxiety and depression was an independent risk factor（HR = 1.876, 95% CI: 1.012–3.477, P = 0.046） for unscheduled return visits in older patients with CHD. Conclusions There is a high prevalence of sarcopenia among hospitalized older adults with CHD. A shorter MACCE-free survival time and more unscheduled return visits are found in sarcopenic older patients with CHD. Clinicians should pay more attention to the functional status of older patients with CHD, as well as identification and management of geriatric syndromes.

Diet was less significant than physical activity in the prognosis of people with sarcopenia and metabolic dysfunction-associated fatty liver diseases: Analysis of the National Health and Nutrition Examination Survey III

Sarcopenia is Associated with the Presence of Nonalcoholic Fatty Liver Disease in Zhejiang Province, China: a Cross-Sectional Observational Study

Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

Metabolic associated fatty liver disease and sarcopenia additively increase mortality: a real-world study

A Combination of Serum Biomarkers in Elderly Patients with Sarcopenia: A Cross-Sectional Observational Study

Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults

Differences in sarcopenia status and mortality according to physical activity: results from the Korean Longitudinal Study on Health and Aging (KLoSHA)

Sarcopenia Contributes to the Progression of Nonalcoholic Fatty Liver Disease- Related Fibrosis: A Meta-Analysis

Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank

Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis

Association between sarcopenia and nutritional status and physical activity among community-dwelling Chinese adults aged 60 years and older.

Sarcopenia is Associated with Short- and Long-Term Mortality in Patients with Acute-on-chronic Liver Failure

Relationship of the Degree of Sarcopenia with the Severity of Nonalcoholic Fatty Liver Disease and Cardiometabolic Risk in Adolescents

Prevalence and Prognostic Implications of Sarcopenia in Older Patients with Coronary Heart Disease.

The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations

Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease

Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity.

Sarcopenia and cognitive impairment in older adults: Long-term prognostic implications based on the National Health and Nutrition Examination Survey (2011-2014)

The relationship between sarcopenia and related bioindicators and changes after intensive lifestyle intervention in elderly East-China populations

ASSOCIATION BETWEEN SARCOPENIA WITH NUTRITION AND EXERCISE IN COMMUNITY-DWELLING OLDER CHINESE

Sarcopenia Imperils Postoperative Long-Term Survival in HCC Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Propensity Score Matching Analysis.